🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ageing of the world's population is accelerating. Despite the health challe...
Status
Unknown
Location
Faculty of Dentistry, National University of Singapore
Start Date
2022-03-29
Trial ID
NCT04946292
Treatments Being Tested
A group of clinicians and researchers developed an 8-session group interven...
Status
Completed
Location
Courage Kenny Research Institute
Start Date
2023-03-08
Trial ID
NCT05780658
Treatments Being Tested
The Improve study is a randomized controlled trial investigating the effica...
Status
Recruiting
Location
Odense University Hospital
Start Date
2024-04-02
Trial ID
NCT06373471
Treatments Being Tested
This protocol describes development and user testing of an educational shar...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-08-15
Trial ID
NCT05497024
Treatments Being Tested
This pilot study evaluates the needs of opioid users for a device-based int...
Status
Completed
Location
Prevention Point Philadelphia
Start Date
2020-08-25
Trial ID
NCT04530591
The goal of this clinical trial is to evaluate the feasibility and acceptab...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-15
Trial ID
NCT07701291
Treatments Being Tested
The primary purpose of this study is to test different methods of measuring...
Status
Completed
Location
Pennington Biomedical Research Center
Start Date
2007-05
Trial ID
NCT01678885
This is a research study to understand and determine the effectiveness of e...
Status
Completed
Location
NYU Langone Health
Start Date
2021-06-17
Trial ID
NCT04218708
This is a two-part study that aims to determine the reliability and safety ...
Status
Completed
Location
University of Pennsylvania
Start Date
2017-08-14
Trial ID
NCT03443388
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested